NOS3 and stroke disorder: Importantly, administration with eNOS inhibitor L‐NAME diminished the protection of HSPA12B in mice survival and neurologic function recovery post‐stroke, suggesting that eNOS‐mediated neuroprotective effects of HSPA12B at chronic phase of ischaemic stroke.